Informed Consent for Chemotherapy: ASCO Member Resources.

Consent to treatment is an important part of the delivery of quality cancer care. Physician practices that participate in ASCO’s Quality Oncology Practice Initiative (QOPI) and others expressed interest in having ASCO provide informed consent resources, and indicated that they would be more likely to use a consent form for chemotherapy if ASCO provided a template. Recent Journal of Oncology Practice articles outlining unique factors in consent for chemotherapy, documentation issues, and malpractice concerns also raised member interest. In response, members of ASCO’s Ethics and Quality of Care Committees formed a joint working group to design a consent form template and other resources that provide a framework for consent conversations between oncologists and patients receiving chemotherapy.

[1]  Thomas J. Smith,et al.  Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  P. Patrizio,et al.  American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  ASCO Recommendations on Fertility Preservation in Cancer Patients: Guideline Summary. , 2006, Journal of oncology practice.

[4]  Dina L. Michels,et al.  Informed Consent and Chemotherapy. , 2005, Journal of oncology practice.

[5]  J. Karlawish,et al.  Identifying ambulatory cancer patients at risk of impaired capacity to consent to research. , 2003, Journal of pain and symptom management.

[6]  O. O’neill,et al.  Some limits of informed consent , 2003, Journal of medical ethics.

[7]  D. S. Gordon,et al.  Cancer care during the last phase of life. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.